Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PGRMC1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SC5D - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ERLEC1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
EID1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
KLHDC2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
LNPK - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FBXL3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RALGAPA1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PAIP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ZDHHC17 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
IMPAD1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CLASP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
HLTF - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
UBA3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ABCE1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MAPK6 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RUFY3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ACAT2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RBM39 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATP2C1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on